Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Blum

Showing results (261-270 of 291) with videos related to

Pageof 30
Sort By:
Journal of Palliative Medicine|June 24, 2026
Understanding Clinicians' Perspectives on End-of-Life Dreams and Visions: An International SurveyMuhammad Hamza Habib, Laura Fontanesi, Zainab Yusufali Motiwala, et al.
Acta Neuropathologica Communications|June 23, 2021
Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathyChing-Pang Chang, Ya-Gin Chang, Pei-Yun Chuang, et al.
Translational Neurodegeneration|April 28, 2026
N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's diseaseSarah Guedjdal, Coline Leghay, Maxime Derisbourg, et al.
Brain : a Journal of Neurology|November 8, 2016
Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathyCyril Laurent, Guillaume Dorothée, Stéphane Hunot, et al.
Neurobiology of Disease|April 1, 2019
New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's diseaseNicolas Sergeant, Valérie Vingtdeux, Sabiha Eddarkaoui, et al.
Scientific Reports|August 12, 2016
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor functionVânia L Batalha, Diana G Ferreira, Joana E Coelho, et al.
Neurobiology of Disease|May 24, 2024
Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neuronsIsabel Paiva, Jonathan Seguin, Iris Grgurina, et al.
Human Molecular Genetics|September 12, 2015
Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathologyMarie-Anne Burlot, Jérôme Braudeau, Kristin Michaelsen-Preusse, et al.
Cell Reports|September 1, 2021
IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's diseaseHelena C Brigas, Miguel Ribeiro, Joana E Coelho, et al.
Progress in Neurobiology|August 15, 2021
P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of TauopathyKevin Carvalho, Elodie Martin, Aurélia Ces, et al.
Pageof 30

Showing results (261-270 of 291) with videos related to

Sort By:
Pageof 30
Journal of Palliative Medicine|June 24, 2026
Understanding Clinicians' Perspectives on End-of-Life Dreams and Visions: An International SurveyMuhammad Hamza Habib, Laura Fontanesi, Zainab Yusufali Motiwala, et al.
Acta Neuropathologica Communications|June 23, 2021
Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathyChing-Pang Chang, Ya-Gin Chang, Pei-Yun Chuang, et al.
Translational Neurodegeneration|April 28, 2026
N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's diseaseSarah Guedjdal, Coline Leghay, Maxime Derisbourg, et al.
Brain : a Journal of Neurology|November 8, 2016
Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathyCyril Laurent, Guillaume Dorothée, Stéphane Hunot, et al.
Neurobiology of Disease|April 1, 2019
New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's diseaseNicolas Sergeant, Valérie Vingtdeux, Sabiha Eddarkaoui, et al.
Scientific Reports|August 12, 2016
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor functionVânia L Batalha, Diana G Ferreira, Joana E Coelho, et al.
Neurobiology of Disease|May 24, 2024
Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neuronsIsabel Paiva, Jonathan Seguin, Iris Grgurina, et al.
Human Molecular Genetics|September 12, 2015
Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathologyMarie-Anne Burlot, Jérôme Braudeau, Kristin Michaelsen-Preusse, et al.
Cell Reports|September 1, 2021
IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's diseaseHelena C Brigas, Miguel Ribeiro, Joana E Coelho, et al.
Progress in Neurobiology|August 15, 2021
P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of TauopathyKevin Carvalho, Elodie Martin, Aurélia Ces, et al.
Pageof 30